Telegram RegisterThe public register of Telegram
Telegram profile photo for PharmBrief | Новости фармации

Channel

PharmBrief | Новости фармации

@PharmBrief

On this record: Growth · Engagement · Reactions · Posts · Citations · Cite this entry

10,366subscribers

+276 since we began measuring on 6 August 2026

Risers and fallers across the register · movement among entries of 10,000–31,623.

Register entry

Telegram ID-1001979639718
TypeChannel
Username@PharmBrief
CreatedBetween 1 April 2023 and 31 October 2023 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded6 August 2026
Last confirmed live1 September 2026
Measurements held26
Confirmed unchanged1 time, most recently 1 September 2026
On Telegramt.me/PharmBrief

Growth

10,09010,36610,2286 August 2026 — 10,090 subscribers6 August 2026 — 10,103 subscribers7 August 2026 — 10,119 subscribers9 August 2026 — 10,117 subscribers9 August 2026 — 10,139 subscribers10 August 2026 — 10,134 subscribers11 August 2026 — 10,141 subscribers12 August 2026 — 10,149 subscribers13 August 2026 — 10,160 subscribers14 August 2026 — 10,172 subscribers16 August 2026 — 10,190 subscribers17 August 2026 — 10,210 subscribers18 August 2026 — 10,230 subscribers19 August 2026 — 10,241 subscribers20 August 2026 — 10,253 subscribers21 August 2026 — 10,262 subscribers23 August 2026 — 10,275 subscribers25 August 2026 — 10,280 subscribers26 August 2026 — 10,294 subscribers27 August 2026 — 10,301 subscribers28 August 2026 — 10,318 subscribers29 August 2026 — 10,330 subscribers29 August 2026 — 10,342 subscribers30 August 2026 — 10,350 subscribers31 August 2026 — 10,354 subscribers1 September 2026 — 10,366 subscribers6 August 20261 September 2026
26 measurements spanning 26 days, net +276. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 10,049–10,407 and does not start at zero.
Measurement log — every subscribers count we have recorded, most recent 20 of 26
Measured (UTC)SubscribersChange
1 Sept 2026, 20:2810,366+12
31 Aug 2026, 19:1510,354+4
30 Aug 2026, 19:0710,350+8
29 Aug 2026, 21:4710,342+12
29 Aug 2026, 01:1810,330+12
28 Aug 2026, 04:0410,318+17
27 Aug 2026, 02:2910,301+7
26 Aug 2026, 03:0810,294+14
25 Aug 2026, 02:4210,280+5
23 Aug 2026, 14:2810,275+13
21 Aug 2026, 23:2610,262+9
20 Aug 2026, 16:2810,253+12
19 Aug 2026, 17:2710,241+11
18 Aug 2026, 20:2610,230+20
17 Aug 2026, 17:3710,210+20
16 Aug 2026, 14:5210,190+18
14 Aug 2026, 20:0810,172+12
13 Aug 2026, 13:3510,160+11
12 Aug 2026, 14:1810,149+8
11 Aug 2026, 15:5110,141first reading

Engagement

58 posts held, back to 24 July 2026the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 39 pages of Telegram’s post history, 20 posts per page.

ERR · 30 days
23.0%
avg views ÷ 10,366 subscribers
Avg views / post
2,380
43 posts measured
Reaction rate
0.861%
reactions ÷ views · ER floor
Posts in window
43
of 58 held

ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.

ER is defined industry-wide as (forwards + reactions + comments) ÷ views — note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate.

What these figures were computed from
WindowRolling 30 days · latest post in window 29 August 2026
Posts held58 (24 July 202629 August 2026)
Views total102,348
Reactions total881
Forwards / commentsnot exposed by the public surface — not measured, not estimated
Readings taken29 Aug 2026, 16:36 UTC

Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.

Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.

Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.

Reaction mix

1,152 reactions across 58 posts, in 13 distinct kinds. The most used accounts for 27.9% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
👀32127.9%
🤔17415.1%
🔥14012.2%
😱988.51%
🤯806.94%
776.68%
726.25%
👍655.64%
👏433.73%
💔332.86%
👎181.56%
🗿161.39%
💊151.30%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 58 of the 58 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 1,152 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 58 most recent posts we hold, published 24 July 2026 to 29 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

29 Aug 2026, 06:15 UTC949 views14 reactionsread 29 August 2026

Слишком жирно Американские работодатели все чаще отказываются оплачивать препараты GLP-1 для снижения веса в рамках медицинских программ для сотрудников. По данным Business Group on Health, доля компаний, покрывающих такие препараты, снизилась с 72% в 2025 году до 60% в 2026-м. Около 14% работодателей уже отказались или планируют отказаться от покрытия в 2027 году. При этом 68% компаний сообщили о росте использовани

👀7🤔4👍2🗿1

28 Aug 2026, 17:16 UTC≈1,100 views9 reactionsread 29 August 2026

Evergreen'им на полную Mounjaro получил новые поводы для назначений. FDA одобрило препарат для снижения риска крупных сердечно-сосудистых рисков (инфаркты, инсульты) у взрослых с диабетом 2-го типа. Мунджаровали мунджаровали да вымунджаровали (не пытайтесь выговорить это вечером в баре, редакция не смогла даже трезывыми) Подписывайтесь на PharmBrief в 💬MAX | 💬TG | 💙VK | 📝 Дзен

👏5👀31

27 Aug 2026, 17:55 UTC≈1,170 views12 reactionsread 29 August 2026

Доначисления ФНС начислила Медхимпрому около ₽170,8 млн налогов и штрафа. Компания признана банкротом в 2022 году. В рамках дела о банкротстве требование ФНС на ₽164,7 млн в 2025 году было признано обоснованным и включено в реестр кредиторов. Причиной налоговых претензий стал формальный документооборот с контрагентами. Подписывайтесь на PharmBrief в 💬MAX | 💬TG | 💙VK | 📝 Дзен

🤔6😱4👀2

27 Aug 2026, 16:09 UTC≈1,190 views20 reactionsread 29 August 2026

Паучье чутье Deutsche Bank мягко намекнул инвесторам, что пора избавляться от акций компании Novo Nordisk. Банк снизил целевую цену бумаг с 290 до 265 датских крон, указав на неспособность компании вернуться к росту 2017 года. После публикации новости акции Novo Nordisk упали на 3%. Не является инвестиционной рекомендацией. Подписывайтесь на PharmBrief в 💬MAX | 💬TG | 💙VK | 📝 Дзен

👀12🤔53

26 Aug 2026, 13:45 UTC≈1,250 views17 reactionsread 29 August 2026

Делайте хорошо, плохо не делайте Bristol Myers Squibb расторгла соглашение с биотехнологической компанией Cellares стоимостью около $380 млн. Договор предусматривал производство CAR-T-терапий, включая препарат Breyanzi (lisocabtagene maraleucel) для лечения ряда B-клеточных лимфом. BMS заявила о несоответствии автоматизированной платформы Cell Shuttle для производства Breyanzi. В чем выражается это несоответствие к

🤔7👏6👀4

26 Aug 2026, 12:23 UTC≈1,280 views24 reactionsread 29 August 2026

Плоды популярности Отисифарм получила разрешение на испытание OTC-TZD-0126 (тразодон). Препарат станет аналогом популярного нынче препарата Триттико компании Angelini. Биоэквивалентность будут сравнивать с оригинальным препаратом до конца 2027 года. Подписывайтесь на PharmBrief в 💬MAX | 💬TG | 💙VK | 📝 Дзен

🔥11👏6🤔6👀1

25 Aug 2026, 11:46 UTC≈1,370 views31 reactionsread 29 August 2026

Ситуация Герофарм потеряла возможность получения субсидий от государства. Причиной стало меткое попадание в реестр недобросовестных поставщиков. Суд отказал Герофарму в принятии обеспечительных мер для сохранения возможности получения тех самых субсидий: [...] компания не доказала неизбежность негативных последствий и точный размер возможных убытков. Подписывайтесь на PharmBrief в 💬MAX | 💬TG | 💙VK | 📝 Дзен

🤯15😱9🤔5👀2

24 Aug 2026, 15:02 UTC≈4,570 views28 reactionsread 29 August 2026

Ешь и худей Калифорнийские исследователи, похоже, смогли воплотить в жизнь мечту миллионов. Экспериментальная молекула TOFA позволяет сжигать жир без значимого снижения мышечной массы при том же потреблении еды. Она одновременно активирует PPARα и PPARδ — ядерные рецепторы, регулирующие экспрессию генов, связанных с захватом и окислением жирных кислот и расходом энергии. А что будет при совместной терапии с препарат

🔥14😱851

24 Aug 2026, 11:31 UTC≈1,410 views14 reactionsread 29 August 2026

Окно Овертоны Замдиректора Совета по внутренней политике Белого дома Хайди Овертон может стать главой FDA. Она классический человек Трампа из числа молодых сторонников, работает в его команде еще с прошлого президентского срока и считается одним из ключевых советников Белого дома по вопросам здравоохранения. Всё больше адептов MAHA (нет, это не опечатка, H от Healthy), получающих должности не из-за профессиональных

🤯92👀2👎1

24 Aug 2026, 09:57 UTC≈1,330 views20 reactionsread 29 August 2026

Последний шанс Японский регулятор одобрил Telomelysin — первый в мире одобренный онколитический аденовирусный препарат для лечения рака пищевода. Препарат предназначен для пациентов, которым невозможно провести хирургическую резекцию или химиолучевую терапию. Коммерческие продажи Telomelysin в Японии начались 21 августа 2026 года. Подписывайтесь на PharmBrief в 💬MAX | 💬TG | 💙VK | 📝 Дзен

👏115👀3👍1

23 Aug 2026, 15:57 UTC≈1,480 views17 reactionsread 29 August 2026

Получите и распишитесь Канал контрабанды сильнодействующих веществ из Индии пресекли российские таможенники. Всего изъято более тысячи капсул и 240 таблеток, содержащих прегабалин, тапентадол и трамадол на ₽1 млн. Организовал схемы 30 летний житель Невиномысска, используя подставных лиц, левые аккаунты в почтовых отделениях и криптоплатежи, а попался он, когда решил сам забрать посылку. Сходил в отделение почты за

🤯9🔥4🤔3🗿1

22 Aug 2026, 06:44 UTC≈1,220 views10 reactionsread 29 August 2026

Volrustomig не смог AstraZeneca остановила КИ экспериментального препарата для лечения метастатического немелкоклеточного рака легкого. Исследователи полагают, что препарат не достигнет ключевой цели по выживаемости. Это не станет окончательным вердиктом для препарата и его изучение продолжат в рамках других исследований. Подписывайтесь на PharmBrief в 💬MAX | 💬TG | 💙VK | 📝 Дзен

🤯5👀2💔2🗿1

Showing the 12 most recent of 58 posts we hold for @PharmBrief. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Citation-graph rank

Citation-graph rank — 53,248 of 1,629,571 entries in the measured graph. A weighted position computed from the forward and mention edges below — republished posts weigh more than named mentions — and recomputed periodically, over the whole graph. Published only as this ordinal position, never as a score: a position is a fact, and a score printed beside one channel’s name would read as a verdict this register does not make. The two counts beneath stay separate for the same reason mentions are never summed with forwards anywhere else on this page — a named-by count costs nothing to manufacture. The top 100 by this measure, or how it is computed.

Forward network

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Named by 13 registered channels — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 1 September 2026 — this entry's latest reading, not the date you are reading this.

“PharmBrief | Новости фармации” (@PharmBrief), 10,366 subscribers as measured 1 September 2026. Telegram Register, tgregister.com/channel/PharmBrief.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.